Literature DB >> 17227290

Paracetamol: new vistas of an old drug.

Alfio Bertolini1, Anna Ferrari, Alessandra Ottani, Simona Guerzoni, Raffaella Tacchi, Sheila Leone.   

Abstract

Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever. It occupies a unique position among analgesic drugs. Unlike NSAIDs it is almost unanimously considered to have no antiinflammatory activity and does not produce gastrointestinal damage or untoward cardiorenal effects. Unlike opiates it is almost ineffective in intense pain and has no depressant effect on respiration. Although paracetamol has been used clinically for more than a century, its mode of action has been a mystery until about one year ago, when two independent groups (Zygmunt and colleagues and Bertolini and colleagues) produced experimental data unequivocally demonstrating that the analgesic effect of paracetamol is due to the indirect activation of cannabinoid CB(1) receptors. In brain and spinal cord, paracetamol, following deacetylation to its primary amine (p-aminophenol), is conjugated with arachidonic acid to form N-arachidonoylphenolamine, a compound already known (AM404) as an endogenous cannabinoid. The involved enzyme is fatty acid amide hydrolase. N-arachidonoylphenolamine is an agonist at TRPV1 receptors and an inhibitor of cellular anandamide uptake, which leads to increased levels of endogenous cannabinoids; moreover, it inhibits cyclooxygenases in the brain, albeit at concentrations that are probably not attainable with analgesic doses of paracetamol. CB(1) receptor antagonist, at a dose level that completely prevents the analgesic activity of a selective CB(1) receptor agonist, completely prevents the analgesic activity of paracetamol. Thus, paracetamol acts as a pro-drug, the active one being a cannabinoid. These findings finally explain the mechanism of action of paracetamol and the peculiarity of its effects, including the behavioral ones. Curiously, just when the first CB(1) agonists are being introduced for pain treatment, it comes out that an indirect cannabino-mimetic had been extensively used (and sometimes overused) for more than a century.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17227290      PMCID: PMC6506194          DOI: 10.1111/j.1527-3458.2006.00250.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN: 1080-563X


  208 in total

Review 1.  Vanilloid (Capsaicin) receptors and mechanisms.

Authors:  A Szallasi; P M Blumberg
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

2.  Metabolism of paracetamol after therapeutic and hepatotoxic doses in man.

Authors:  M Davis; D Labadarios; R S Williams
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

3.  The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen (40 mg/kg) in adults: a double-blinded, randomized study.

Authors:  D H Beck; M R Schenk; K Hagemann; U R Doepfmer; W J Kox
Journal:  Anesth Analg       Date:  2000-02       Impact factor: 5.108

4.  Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants.

Authors:  T G Hansen; K O'Brien; N S Morton; S N Rasmussen
Journal:  Acta Anaesthesiol Scand       Date:  1999-09       Impact factor: 2.105

5.  Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

Authors:  D Melck; T Bisogno; L De Petrocellis; H Chuang; D Julius; M Bifulco; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1999-08-19       Impact factor: 3.575

6.  Morphine-sparing effect of acetaminophen in pediatric day-case surgery.

Authors:  R Korpela; P Korvenoja; O A Meretoja
Journal:  Anesthesiology       Date:  1999-08       Impact factor: 7.892

7.  Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review.

Authors:  H J McQuay; R A Moore
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

8.  Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.

Authors:  R A van Lingen; J T Deinum; J M Quak; A J Kuizenga; J G van Dam; K J Anand; D Tibboel; A Okken
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

9.  Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease.

Authors:  M Mitić-Zlatković; V Stefanović
Journal:  Ren Fail       Date:  1999-09       Impact factor: 2.606

10.  Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure.

Authors:  O Detry; N Arkadopoulos; P Ting; E Kahaku; F D Watanabe; J Rozga; A A Demetriou
Journal:  Am Surg       Date:  1999-10       Impact factor: 0.688

View more
  111 in total

1.  A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians.

Authors:  Nicolino Ruperto; Luigi Carozzino; Roberto Jamone; Federico Freschi; Gianfranco Picollo; Marcella Zera; Ornella Della Casa Alberighi; Enrica Salvatori; Alessandra Del Vecchio; Paolo Dionisio; Alberto Martini
Journal:  Ital J Pediatr       Date:  2011-09-29       Impact factor: 2.638

2.  Efficacy of Photobiomodulation Therapy for Orthodontic Pain Control Following the Placement of Elastomeric Separators: A Randomized Clinical Trial.

Authors:  AmirHossein Mirhashemi; Seyedreza Rasouli; Shiva Shahi; Nasim Chiniforush
Journal:  J Lasers Med Sci       Date:  2021-02-22

Review 3.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

Review 4.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 5.  Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.

Authors:  Isabella Sudano; Andreas J Flammer; Susanne Roas; Frank Enseleit; Georg Noll; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

6.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

7.  Salicytamide: a New Anti-inflammatory Designed Drug Candidate.

Authors:  Karen Marinho Maciel Guedes; Rosivaldo Santos Borges; Enéas Andrade Fontes-Júnior; Andressa Santa Brigida Silva; Luanna Melo Pereira Fernandes; Sabrina Carvalho Cartágenes; Ana Carla Godinho Pinto; Mallone Lopes Silva; Luana Melo Diogo Queiroz; José Luís Fernandes Vieira; Pergentino José Cunha Sousa; Cristiane Socorro Ferraz Maia
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

8.  Population pharmacokinetics of intravenous acetaminophen in Japanese patients undergoing elective surgery.

Authors:  Tsuyoshi Imaizumi; Shinju Obara; Midori Mogami; Yuzo Iseki; Makiko Hasegawa; Masahiro Murakawa
Journal:  J Anesth       Date:  2017-04-21       Impact factor: 2.078

9.  [Pediatric perioperative systemic pain therapy: Austrian interdisciplinary recommendations on pediatric perioperative pain management].

Authors:  B Messerer; G Grögl; W Stromer; W Jaksch
Journal:  Schmerz       Date:  2014-02       Impact factor: 1.107

10.  Metabolism of acetaminophen (paracetamol) in plants--two independent pathways result in the formation of a glutathione and a glucose conjugate.

Authors:  Christian Huber; Bernadett Bartha; Rudolf Harpaintner; Peter Schröder
Journal:  Environ Sci Pollut Res Int       Date:  2009-01-15       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.